ABEONA THERAPEUTICS INC. (ABEO) Operating cash flow 2016–2025
ABEONA THERAPEUTICS INC. (ABEO) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$76.3MFY2025 · since FY2016: -$13.0M → -$76.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$76.3M | -36.3% |
| FY2024 | -$56.0M | -51.4% |
| FY2023 | -$37.0M | +14.9% |
| FY2022 | -$43.5M | +33.8% |
| FY2021 | -$65.7M | -87.5% |
| FY2020 | -$35.0M | +44.3% |
| FY2019 | -$62.8M | -60.6% |
| FY2018 | -$39.1M | -72.6% |
| FY2017 | -$22.7M | -74.1% |
| FY2016 | -$13.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ABEO financial trends
ABEO RevenueABEO Net incomeABEO Net marginABEO Gross profitABEO Gross marginABEO Operating incomeABEO Operating marginABEO Free cash flowABEO Capital expendituresABEO Return on equityABEO Stock buybacksABEO Dividends paidABEO Total assetsABEO Total liabilitiesABEO Shareholders’ equityABEO overview →